Understanding how SARS-CoV-2 infection and genetics affect Alzheimer's disease risk
Official title: Administrative Core
Funded at University of Texas Hlth Science Center · NIH-10907422 · Data updated 2026-11-12
This study is looking at how getting COVID-19 might affect the chances of developing Alzheimer's disease, and it's designed for anyone interested in understanding the connection between these two health issues.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Hlth Science Center NIH-funded |
| Lab location | 1 site (San Antonio, United States) |
| Project start | August 15, 2023 |
| Project end | July 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $3,077,212 |
| NIH project number | 5U19AG076581-02 |
| Project ID | NIH-10907422 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals at risk for Alzheimer's disease, particularly those with a history of SARS-CoV-2 infection.
✕Less likely to help
Patients who do not have a risk of Alzheimer's disease or have not been infected with SARS-CoV-2 may not benefit from this research.
What this research studies
This research focuses on the interactions between SARS-CoV-2 infection and genetic variations that may influence the risk of developing Alzheimer's disease. The Administrative Core will coordinate various projects and cores involved in this study, ensuring effective management of resources and data. It will facilitate the transfer of biological samples and oversee compliance across multiple international sites. By integrating scientific activities, the core aims to enhance collaboration and communication among researchers.
Why it matters
Potential benefit: If successful, this research could lead to better understanding and potentially new strategies for preventing or treating Alzheimer's disease.
How similar studies have gone: While the specific interactions being studied are novel, previous research has shown that understanding genetic factors and infections can provide insights into Alzheimer's disease.
Where this research is happening
-
University of Texas Hlth Science Center
San Antonio, United States Active
Researchers
- Principal investigator: De Erausquin, Gabriel Alejandro — University of Texas Hlth Science Center
- Study coordinator: De Erausquin, Gabriel Alejandro
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.